Koppel Adam
- SEC CIK
- 0001578965
In the past year, 1 open-market purchase filing worth $25.0M and no sales.
Current role at each company
- KLRA Kailera Therapeutics, Inc.Director, 10% Owneras of Apr 20, 2026
- FHTX Foghorn Therapeutics Inc.Directoras of Dec 30, 2024
- CERE Cerevel Therapeutics Holdings, Inc.Director, 10% Owneras of Aug 5, 2024
- SLDB Solid Biosciences Inc.Director, 10% Owneras of Jan 12, 2024
- APTX Aptinyx Inc.Director, 10% Owneras of May 31, 2022
Show 3 more companies
- DRNA Dicerna Pharmaceuticals IncDirectoras of Dec 29, 2021
- SWTX SpringWorks Therapeutics, Inc.10% Owneras of Aug 12, 2021
- RPID Rapid Micro Biosystems, Inc.10% Owneras of Jul 21, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.0M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Koppel Adam as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KLRA Kailera Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Koppel AdamDirector, 10% Owner | PPurchase | +1.56M | $16.00 | +$25.0M | +7.4%22.6M after |
CERE Cerevel Therapeutics Holdings, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Koppel AdamDirector, 10% Owner | PPurchase | +5.48M | $22.81 | +$125.0M | +9.1%65.7M after | Duplicate filing |
SWTX SpringWorks Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 (view filing)8:38 PM ET | Aug 10 | 2 days | Schwartz Jeffrey Lawrence and 3 othersDirector, 10% Owner | SSale | −1.00M | $70.25 | −$70.3M | −17.1%4.83M after |
RPID Rapid Micro Biosystems, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2021 (view filing)4:40 PM ET | Jul 19 | 2 days | Schwartz Jeffrey Lawrence and 5 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +100.0K | $20.00 | +$2.00M | +1.2%8.43M after |